FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to hemostatic glue. Hemostatic glue represents an aqueous solution containing 10-100 g of cellulose, 1-30 ml of acetic acid and 1-150 g of feracryl in 1 l of distilled water. Invention provides cessation of bleeding and film formation in contact of this glue with blood and tissues for 30 s.
EFFECT: improved and valuable medicinal properties of glue.
3 ex
Title | Year | Author | Number |
---|---|---|---|
HEMOSTATIC GLUE | 2004 |
|
RU2256448C1 |
HAEMOSTATIC AGENT | 2004 |
|
RU2275201C2 |
HEMOSTATIC GLUE | 2004 |
|
RU2257901C1 |
HEMOSTATIC GLUE | 2004 |
|
RU2270015C1 |
HEMOSTATIC GLUE | 2004 |
|
RU2270016C2 |
HAEMOSTATIC GLUE POWDER | 2005 |
|
RU2304440C2 |
EFFICIENT HEMOSTATIC MEDICATION BASED ON LITHIUM AND DOUBLE LITHIUM-ZINC SALT OF POLYACRYLIC ACID | 2008 |
|
RU2424813C2 |
HAEMOSTATIC SPONGE AND METHOD FOR ITS PREPARATION | 2016 |
|
RU2618896C1 |
HEMOSTATIC COATING IN FORM OF SPONGE OR FILM (VERSIONS) | 2016 |
|
RU2639379C1 |
HEMOSTATIC SPONGE (VERSIONS) | 2016 |
|
RU2627855C1 |
Authors
Dates
2005-10-27—Published
2004-07-23—Filed